Dietary Fat Reduction Improves Long-Term Survival in ER-negative Breast Cancers
Reducing dietary fat intake appears to improve survival rates among women with certain types of breast cancer.
Reducing dietary fat intake appears to improve survival rates among women with certain types of breast cancer.
Ultrasound breast screenings for women with dense breast tissue improves cancer detection.
Adding ovarian function suppression (OFS) is associated with several patient-reported endocrine symptoms and impacts sexual functioning.
Adding ovarian function suppression (OFS) to adjuvant postsurgical tamoxifen therapy can reduce breast cancer recurrence.
TP53 mutation, but not PIK3CA status, predicts treatment response in HER2-positive breast cancer.
PIK3CA mutation status and PAM50 tumor subtype do not predict poor trastuzumab response in the adjuvant setting.
Capecitabine monotherapy does not improve outcomes in elderly patients with moderate- or high-risk early breast cancer.
FEC-100 does not yield improved outcomes over standard doxorubicin (adriamycin) with cyclophosphamide (AC) therapy in breast cancer.
Carboplatin is associated with better outcomes than docetaxel in individuals with BRCA1/2 mutation-harboring breast cancer.
Nanoparticle albumin-bound paclitaxel (nab-paclitaxel or nP) for breast cancer associated with improved pathologic complete response.